The rate of dihydroethidium oxidation was significantly elevated in Gaucher disease, Parkinson’s disease with GBA mutations, the homozygous E326K and non-manifesting carrier fibroblasts accompanied by depletion of glutathione levels. This evidence concerns the gene GBA1 and Gaucher disease.